Evidence map›Paper›PMID 26703678›Full record

ArticleInternational journal of environmental research and public health2015

Computer Optimization of Biodegradable Nanoparticles Fabricated by Dispersion Polymerization.

Emmanuel O Akala, Simeon Adesina, Oluwaseun Ogunwuyi

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emmanuel O AkalaCenter for Drug Research and Development, Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, 2300 4th Street NW, Washington, DC 20059, USA. eakala@howard.edu.
Simeon AdesinaCenter for Drug Research and Development, Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, 2300 4th Street NW, Washington, DC 20059, USA. simeon.adesina@howard.edu.
Oluwaseun OgunwuyiCenter for Drug Research and Development, Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, 2300 4th Street NW, Washington, DC 20059, USA. temytayoo@yahoo.com.

Funding

EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM: REN*: PROSTATE BREAST CANCERC06RR020608 · NCRR · HOWARD UNIVERSITY · PI ADDERLEY-KELLY, BEATRICE · 2004 to 2004
$3.5M
RENOVATION THIRD FLOOR CHAUNCEY I. COOPER HALL-PHARMACYC06RR014469 · NCRR · HOWARD UNIVERSITY · PI LECCA, PEDRO J · 2000 to 2000
$1.0M
Novel Nanotechnology Platform for Breast Cancer TreatmentSC1CA199810 · NCI · HOWARD UNIVERSITY · PI AKALA, EMMANUEL O · 2015 to 2018
$969k
NCI NIH HHS 1SC1CA199810-01NCI NIH HHS SC1 CA199810NCRR NIH HHS 1 C06 RR 020608-01NCRR NIH HHS 1 C06 RR 14469-01NCRR NIH HHS C06 RR014469NCRR NIH HHS C06 RR020608PHS HHS 5P30A1087714-02
6 · The paper itself

Abstract

Quality by design (QbD) in the pharmaceutical industry involves designing and developing drug formulations and manufacturing processes which ensure predefined drug product specifications. QbD helps to understand how process and formulation variables affect product characteristics and subsequent optimization of these variables vis-à-vis final specifications. Statistical design of experiments (DoE) identifies important parameters in a pharmaceutical dosage form design followed by optimizing the parameters with respect to certain specifications. DoE establishes in mathematical form the relationships between critical process parameters together with critical material attributes and critical quality attributes. We focused on the fabrication of biodegradable nanoparticles by dispersion polymerization. Aided by a statistical software, d-optimal mixture design was used to vary the components (crosslinker, initiator, stabilizer, and macromonomers) to obtain twenty nanoparticle formulations (PLLA-based nanoparticles) and thirty formulations (poly-ɛ-caprolactone-based nanoparticles). Scheffe polynomial models were generated to predict particle size (nm), zeta potential, and yield (%) as functions of the composition of the formulations. Simultaneous optimizations were carried out on the response variables. Solutions were returned from simultaneous optimization of the response variables for component combinations to (1) minimize nanoparticle size; (2) maximize the surface negative zeta potential; and (3) maximize percent yield to make the nanoparticle fabrication an economic proposition.

Indexed as

Computer-Aided DesignPolymerizationChemistry, PharmaceuticalDrug IndustryNanoparticlesParticle SizeTechnology, Pharmaceuticalcomputer optimizationdispersion polymerization">d-optimal mixture designnanoparticlesquality by design (QbD)statistical design of experiments

Identifiers

PMID26703678
PMCPMC4730438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.